Svelta Labs Education & Research Journal
Fresh editorial content for peptide research, skincare science, wellbeing categories, Svelta-GPT updates, and research-use product guidance.
TQF3250 Clinical Trial: Phase 1b Diabetes Research
Read the TQF3250 Phase 1b trial design for type 2 diabetes and overweight or obesity, including safety outcomes and the limits of early research.
GLP-1 Muscle Loss and Powerlifting: What to Monitor
Explore muscle-loss concerns around GLP-1 medicines and powerlifting, including strength, nutrition, recovery and the limits of body-composition measures.
Weight Loss Injections and Gallstones: Questions to Ask
Have gallstones and considering weight loss injections? Understand the questions for a prescriber, relevant history and symptoms needing urgent help.
Restarting Wegovy After a Break: UK Review Checklist
Restarting Wegovy after a break? Check the right UK leaflet, prepare your treatment history and understand why multiple missed doses need review.
Mounjaro Itching: Skin and Injection-Site Reactions
Understand Mounjaro itching, recognised injection-site reactions, other possible causes and symptoms that need prompt medical attention.
Retatrutide Claims Online: How to Check the Evidence
Check retatrutide claims against trial and regulatory information. Learn why online prices, seller claims and anecdotes are not proof of approval.
Restarting Mounjaro After a Break and Weight Regain
Considering restarting Mounjaro after a break? Understand what a personal account can show and which questions to take to your prescribing team.
Switching from Mounjaro to Wegovy: What to Discuss
Compare Mounjaro and Wegovy, understand why side effects vary, and prepare questions for a prescriber before changing weight-management medicines.
Starting Mounjaro: Portion Control and Everyday Support
Starting Mounjaro? Explore portion control, appetite, daily routines and community support, while keeping personal experiences separate from medical advice.
Weight-Loss Injection Eligibility Below BMI 27: What Off-Label Means
Starting treatment below BMI 27 is different from reaching that BMI during weight maintenance. Learn how initial BMI, indication and NHS criteria differ.
Retatrutide Approval Status: Clinical Trials, Not a Licensed Rollout
Retatrutide remains investigational in the manufacturer’s current information. Claims of a limited public rollout should not be confused with clinical-trial access.
First Mounjaro Injection Nerves: Preparation and Support
First-injection nerves are understandable. Focus on knowing whom to ask, using the supplied instructions and getting support if anxiety makes treatment difficult.
